Skip to content

Medical-device intelligence

LGI: Fluorescence Polarization Immunoassay, Carbamazepine

FDA product code LGI: Fluorescence Polarization Immunoassay, Carbamazepine. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
LGI
FDA device name
Fluorescence Polarization Immunoassay, Carbamazepine
Device class
2
Regulation number
862.3645
Medical specialty
Clinical Toxicology
Review panel
TX

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore clinical toxicology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

3 clearance records and 4 recall records in the covered releases, across 4 source company names and 1 product codes. Dated history runs from Apr 12, 1990 to May 31, 2007.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
LGI · Fluorescence Polarization Immunoassay, Carbamazepine34

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

7 matching records
Device / recordCompany in FDA recordSourceSource date
AxSYM Quinidine Standard Calibrators - consist of six bottles of Cal A (6ml) and Cals B-F (4ml each)-Product List Number-7A73-01Z-1185-2007 · LGIAbbott Diagnostic International, Ltd.RecallAug 22, 2007FDA classification date
AxSYM Quinidine Controls - are composed of 3 bottles of controls (AxSYM 8mL & XSYSTEM 2.5mL -Control Low, Control Medium, Control High) containin…Z-1186-2007 · LGIAbbott Diagnostic International, Ltd.RecallAug 22, 2007FDA classification date
XSYSTEMS Quinidine Calibrators consists of six bottles of Cal A-F (2.5 mL each).-Product List Number-9506-01Z-1187-2007 · LGIAbbott Diagnostic International, Ltd.RecallAug 22, 2007FDA classification date
XSYSTEMS Quinidine Controls are composed of 3 bottles of controls (AxSYM 8mL & XSYSTEM 2.5ml) containing quinidine prepared in human serum to yie…Z-1188-2007 · LGIAbbott Diagnostic International, Ltd.RecallAug 22, 2007FDA classification date
FLUORESCENCE POLARIZATION IMMUNOASSAY CARBAMAZEPINEK944063 · LGISigma Diagnostics, Inc.510(k)Nov 10, 1994FDA decision date
AXSYM(TM) QUINIDINEK940682 · LGIAbbott Laboratories510(k)Jun 21, 1994FDA decision date
MODIFIED ACCUFLUOR CARBAMAZEPINE REAGENT & CALIBRAK900702 · LGIInnotron of Oregon, Inc.510(k)Apr 12, 1990FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗